Clinical trial
Antidiabetic Potential of Galician High-phenolic Extra Virgin Olive Oils in Patients With Type 2 Diabetes
NCT06757751 is registered in ClinicalTrials.gov with Fundacin Biomedica Galicia Sur as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Antidiabetic Potential of Galician High-phenolic Extra Virgin Olive Oils in Patients With Type 2 Diabetes
- Lead sponsor
- Fundacin Biomedica Galicia Sur
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 30, 2021
- Completion date
- September 30, 2022
- Enrollment
- 116 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.